Signals
Platform Powered By EquityPandit

Cash Intraday
Signals

Option
Signals

Stock Future
Intraday Signals

Swing Trading
Signals

Investment
Opportunities

Stock
Signals

Join Now

Glenmark Life Sciences Ltd

NSE :GLS   BSE :543322  Sector : Pharmaceuticals
Buy, Sell or Hold GLS? Ask The Analyst

BSE

prev close

OPEN PRICE

bid price (qty)

offer price (qty)

volume

Today's low / high

52 WK low / high

NSE

prev close

open price

bid price (qty)

offer price (qty)

volume

Today's' low / high

52 WK low / high

24 Dec
958.40
(-3.57%)
23 Dec
993.90
(-1.91%)
20 Dec
1013.30
(-0.38%)
19 Dec
1017.15
(-1.37%)
18 Dec
1031.25
(1.92%)
17 Dec
1011.85
(-1.61%)
16 Dec
1028.40
(1.01%)
13 Dec
1018.15
(-1.76%)
12 Dec
1036.35
(-1.29%)
11 Dec
1049.85
(0.96%)
10 Dec
1039.90
(0.99%)
09 Dec
1029.75
(-2.54%)
06 Dec
1056.55
(-1.73%)
05 Dec
1075.15
(-1.85%)
04 Dec
1095.40
(0.92%)
03 Dec
1085.40
(1.29%)
02 Dec
1071.55
(-1.16%)
29 Nov
1084.10
(0.32%)
28 Nov
1080.60
(-0.20%)
27 Nov
1082.80
(1.37%)
26 Nov
1068.20
(-2.24%)

Price Chart Historical Data Technical Chart

Technical Analysis

Short Term Investors

Very Bearish
Medium Term Investors

Very Bearish
Long Term Investors

Bullish

Moving Averages

5 DMA
Bearish

1002.35

10 DMA
Bearish

1015.27

20 DMA
Bearish

1042.87

50 DMA
Bearish

1064.29

100 DMA
Bearish

1075.4

200 DMA
Bullish

949.77


Intraday Support and Resistance
(Based on Pivot Points) |

Updated On Dec 24, 2024 04:00 PM For Next Trading Session

Pivots Classic Fibonacci Camarilla Woodie DM
R3 1030.1 1014.4 970.42 - -
R2 1014.4 997.71 966.41 1011.33 -
R1 986.4 987.39 962.41 980.26 1000.4
P 970.7 970.7 970.7 967.63 977.7
S1 942.7 954.01 954.39 936.56 956.7
S2 927 943.69 950.39 923.93 -
S3 899 927 946.38 - -

Key Metrics

Shareholding Pattern

  75% Total Promoter Holding
2.82% Mutual Fund Holdings
7.85% FIIs
12.98% Non Institution
0.08% Insurance Companies
0% Custodians
1.27% Other Parties

Shareholding History

Quarterly Result (Figures in Rs. Crores)


Glenmark Life Sciences Ltd Quaterly Results


INCOME
PROFIT
EPS

Glenmark Life Sciences Ltd Quaterly Results


INCOME600.73 574.5 539.73 594.11 515.41
PROFIT118.74 118.77 97.94 111.48 95.32
EPS9.69 9.69 7.99 9.1 7.78

Profit & Loss (Figures in Rs. Crores)


Glenmark Life Sciences Ltd Profit & Loss


INCOME
PROFIT
EPS

Glenmark Life Sciences Ltd Profit & Loss


Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
INCOME 0.2 1188.45 1553.94 1956.68 2096.59 2274.62 2351.82
PROFIT -0.43 196.13 314.01 352.02 419.27 467.37 471.42
EPS -434 997.92 1597.44 358.76 34.17 38.11 38.43

Balance Sheet (Figures in Rs. Crores)
Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018
SOURCES OF FUNDS :
Share Capital 24.5124.5124.511.961.961.960.01
Reserves Total 2,307.822,113.72,029.81750.79399.7386.17-1.41
Total Shareholders Funds2,332.332,138.212,054.32752.75401.6988.13-1.4
Unsecured Loans 17.1519.362.8800.020.020
Total Debt17.1519.362.8800.020.020
Other Liabilities15.777.8700000
Total Liabilities2,365.252,165.442,057.2752.75401.7188.15-1.4
APPLICATION OF FUNDS :
Gross Block 1,012.33936.48705.53651.9594.82475.570
Less : Accumulated Depreciation 207.26155.85115.7779.148.5819.260
Net Block 805.07780.63589.76572.8546.24456.310
Capital Work in Progress105.9961.6296.9614.110.7380.390
Investments 0.080.080.080.080.080.080
Inventories 666.59604.17516.24513.42412.78400.840.04
Sundry Debtors 765.43806.77673.49619.5638.63448.090.03
Cash and Bank Balance301.59309.4512.16115.6102.060.01
Loans and Advances 182.38130.0162.69150.5298.7179.70.01
Total Current Assets1,9161,850.341,764.591,399.041,160.12930.690.08
Current Liabilities 424.35479.53355.881,187.851,285.11,3641.47
Provisions 12.0314.7526.4433.622.3416.40.01
Total Current Liabilities & Provisions436.38494.28382.321,221.441,307.441,380.391.48
Net Current Assets1,479.621,356.071,382.27177.59-147.33-449.7-1.4
Deferred Tax Assets4.551.811.072.030.132.290
Deferred Tax Liability53.3444.2532.5724.9116.589.140
Net Deferred Tax-48.79-42.44-31.5-22.88-16.45-6.850
Other Assets23.299.4919.6311.068.447.920
Total Assets2,365.252,165.452,057.2752.75401.7288.15-1.4
Contingent Liabilities4.822.222.222.222.222.760

Cash Flow (Figures in Rs. Crores)

Net Profit before Tax and Extr...631.29
Depreciation53.45
Interest (Net)-10.48
P/L on Sales of Assets0.7
Prov. and W/O (Net)31.48
P/L in Forex-0.27
Total Adjustments (PBT and Ext...79.27
Operating Profit before Workin...710.56
Trade and 0ther Receivables-17.33
Inventories-82.63
Trade Payables-34.12
Total Adjustments (OP before W...-134.08
Cash Generated from/(used in) ...576.48
Direct Taxes Paid-162.96
Total Adjustments(Cash Generat...-162.96
Cash Flow before Extraordinary...413.52
Net Cash from Operating Activi...413.52
Purchased of Fixed Assets-128.97
Sale of Fixed Assets0.47
Interest Received12.02
Net Cash used in Investing Act...-116.48
Of Financial Liabilities-2.21
Dividend Paid-275.69
Interest Paid-1.55
Net Cash used in Financing Act...-279.44

Company Details

Registered Office
AddressPlot No. 170-172 Chandramouli,
Industrial Est.Mohol Bazarpeth
CitySolapur
StateMaharashtra
Pin Code413213
Tel. No.91-2189-234456/234246
Fax. No.
Emailcomplianceofficer@glenmarklifesciences.com
Internethttp://www.glenmarklifesciences.com
Registrars
AddressPlot No. 170-172 Chandramouli
CitySolapur
StateMaharashtra
Pin Code413213
Tel. No.91-2189-234456/234246
Fax. No.
Emailcomplianceofficer@glenmarklifesciences.com
Internethttp://www.glenmarklifesciences.com
Management
Name Designation
Yasir Yusufali RawjeeManaging Director & CEO
Vinod NaikExecutive Director
Manju AgarwalIndependent Non Exe. Director
Taruvai Laxminarayanan EaswarIndependent Non Exe. Director
HIREN KARSANBHAI PATELChairman (Non-Executive)
KAUSHIKBHAI NANDUBHAI PATELIndependent Director
VIJAYKUMAR RATILAL SHAHIndependent Director
Savan GodialwalaIndependent Director
Rudalf CorrieaCompany Sec. & Compli. Officer